Literature DB >> 7256824

Inhibition of human natural killer activity by cyclosporin A.

M Introna, P Allavena, F Spreafico, A Mantovani.   

Abstract

The effect of in vitro exposure to cyclosporin A on human natural killer (NK) activity was investigated using peripheral blood lymphocytes as effectors and 51Cr-labeled K562 cells as targets. After preincubation of the effectors with the drug for 20 hr, a dose-dependent reduction of NK activity was observed at concentrations ranging from 0.1 to 10 micrograms/ml. Exposure to the drug during the 20-hr preincubation and the 4-hr 51Cr-release assay resulted in greater impairment of NK cytotoxicity than preincubation alone, whereas the drug, present only during the assay, had no effect on cytolytic activity. Inhibition of NK activity required a minimal exposure time to the drug of 8 hr. The inhibitory effect of cyclosporin A on NK activity was rapidly reversible as, after a 20-hr incubation with 19 micrograms/ml, complete recovery of cytotoxicity was already observed after a further 4-hr culture in medium. Partially purified human fibroblast interferon augmented NK activity even in the presence of high concentrations (10 micrograms/ml) of cyclosporin A.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7256824     DOI: 10.1097/00007890-198102000-00004

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  24 in total

1.  The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations.

Authors:  Hongbo Wang; Bartosz Grzywacz; David Sukovich; Valarie McCullar; Qing Cao; Alisa B Lee; Bruce R Blazar; David N Cornfield; Jeffrey S Miller; Michael R Verneris
Journal:  Blood       Date:  2007-05-10       Impact factor: 22.113

Review 2.  The influence of cyclosporin A on cell-mediated immunity.

Authors:  A W Thomson; L M Webster
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

3.  Natural killer-cell activity in cyclosporine-treated renal allograft recipients.

Authors:  M Lefkowitz; J Kornbluth; J E Tomaszewski; D K Jorkasky
Journal:  J Clin Immunol       Date:  1988-03       Impact factor: 8.317

4.  Cyclosporin A: pharmacologic activity on the immune system and effects in clinical organ transplantation.

Authors:  L H Block; P M Sutter; M J Mihatsch
Journal:  Klin Wochenschr       Date:  1983-11-02

5.  Inhibition of mouse natural killer activity by cyclosporin A.

Authors:  R H Yanagihara; W H Adler
Journal:  Immunology       Date:  1982-02       Impact factor: 7.397

6.  Improved outcome of renal transplantation with cyclosporine compared with azathioprine--experience in 33 recipients followed for over one year.

Authors:  T Yasumura; Y Ohmori; I Aikawa; M Fukuda; S Suzuki; I Nakai; S Matsui; T Oka
Journal:  Jpn J Surg       Date:  1986-05

7.  Renal transplant immunosuppression impairs natural killer cell function in vitro and in vivo.

Authors:  Olivier Morteau; Samkeliso Blundell; Aron Chakera; Sophia Bennett; Charita M Christou; Philip D Mason; Richard J Cornall; Christopher A O'Callaghan
Journal:  PLoS One       Date:  2010-10-12       Impact factor: 3.240

8.  Calcineurin-dependent lytic granule exocytosis in NK-92 natural killer cells.

Authors:  Arun T Pores-Fernando; Surabhi Gaur; Michelle Y Doyon; Adam Zweifach
Journal:  Cell Immunol       Date:  2008-08-30       Impact factor: 4.868

9.  Natural cytotoxicity of rat hepatic natural killer cells and macrophages against a syngeneic colon adenocarcinoma.

Authors:  L Bouwens; R Jacobs; L Remels; E Wisse
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

10.  Effect of cyclosporin A on murine natural killer cells.

Authors:  X Gui; M Ho; P E Camp
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.